ArticleMedical physics2026
PlanningCopilot: An agentic framework integrating ESAPI modules for autonomous treatment planning in lung radiotherapy.
Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundConsistently generating clinically acceptable plans without human intervention remains a challenge in radiotherapy. Rule-based automation provides deterministic execution, and knowledge-based planning (KBP) provides statistical dose estimation, but both often require manual refinement. Large language models (LLMs) offer clinical reasoning capability, but effective autonomous planning also requires a mechanism to execute complex planning actions within the treatment planning system (TPS). PURPOSE: To develop and evaluate PlanningCopilot, an agentic system that utilizes the reasoning capability of LLM and a validated Eclipse Scripting API (ESAPI) optimization module integrating KBP initialization ("PlanAct") to autonomously generate treatment plans. This study evaluates the system's ability to produce clinically acceptable plans for locally advanced non-small cell lung cancer (LA-NSCLC) and assesses its potential to refine performance by self-learning.
methodsPlanningCopilot was implemented as a multi-agent framework linked to the TPS through PlanAct API. It comprises four specialized GPT-4.1 agents that iteratively interact with the TPS: (1) an Evaluator agent that accesses the plan and generates plan quality reports, (2) a Supervisor agent that validates these reports before passing them to a Planner agent, (3) the Planner agent that executes initialization and optimization tasks through PlanAct API and planning guidelines, and (4) an optional Learner agent that synthesizes optimization history into Planner-facing prompt addendums. We retrospectively analyzed 62 patients with conventionally fractionated LA-NSCLC and compared original clinical plans with autonomous plans with and without the Learner agent. Measurement-based patient-specific quality assurance (PSQA) was performed on the first 21 autonomous IMRT plans in planning order.
resultsAll autonomous plans met clinical dosimetric requirements, including those not achieved in the clinical plans and KBP (RapidPlan) plans. Paired Wilcoxon signed-rank tests showed no significant differences between autonomous and clinical plans for Lungs D
conclusionPlanningCopilot enables autonomous generation of clinically acceptable and deliverable treatment plans for LA-NSCLC. It consistently satisfies clinical dosimetric requirements across varying anatomical complexities and improves optimization efficiency through self-learning from prior optimization history.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.